The pro-peptide argument isn't that these substances are proven cures, but that a regulated "white market" is safer than the current gray market. By moving production to GMP-certified compounding pharmacies under FDA oversight, the goal is to reduce harm from a dodgy, unregulated supply chain that already exists.

Dorian Yates warns that any muscle gained with anabolic steroids is temporary. When you stop, not only do the physical gains disappear, but your natural hormone production is suppressed, often leading to depression. This creates a powerful incentive to get "back on" the merry-go-round.

Online vendors legally sell unregulated peptides by labeling them "for research only," while simultaneously providing syringes, tutorials, and marketing that normalizes human injection. This strategy exploits a regulatory loophole to create a thriving market for untested performance-enhancing drugs.

Within the wide, normal range of testosterone for both men and women, hormone levels are not predictive of one's ability to gain muscle. Only supra-physiological levels, such as those from anabolic steroids, create a significant, predictable advantage in muscle growth.

The practice of storing athlete samples for 10 years for future retesting acts as a significant deterrent. It removes the finality of "getting away with it," forcing cheaters to live with the constant anxiety that technological advancements could expose them at any moment, tarnishing their legacy long after their victory.

Contrary to the belief that athletes are always seeking an edge, USADA CEO Travis Tygart argues the majority are driven by a moral code. The idea of winning illegitimately is antithetical to their self-perception as true competitors, making this internal compass a more powerful deterrent than the fear of being caught.

Travis Tygart explains that organizations responsible for both promoting a sport and policing its athletes face a fundamental conflict. The financial incentive to create heroes and compelling stories, like Lance Armstrong's, often leads them to ignore or cover up cheating to protect revenue streams and sponsorship deals.

Proponent Max Marchione argues the debate isn't between using peptides or not, but between an unsafe gray market and a regulated 'white market.' He contends that since people already use them, legalizing their production in GMP-certified facilities under FDA oversight is the safest path forward to reduce net harm.

A key anti-doping innovation, the Athlete Biological Passport, shifts the focus from detecting a specific banned substance to monitoring an athlete's biological markers over time. By comparing an individual to their own baseline, it can identify unnatural fluctuations that indicate doping, even without a positive test for a specific drug.